Stem Cell Therapy for Perianal Crohn’s Disease

Aim. To compare the effectiveness of the effect of combination therapy (local and systemic administration) with bone marrow mesenchymal stromal cells (MSC), anticlitokine therapy with infliximab (IFX), and antibiotic (AB)/immunosuppressive (IS) therapy on the frequency of healing of simple perianal...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: O V Knyazev, N A Fadeeva, A V Kagramanova, N I Belyakov, N V Orlova, A A Lishchinskaya, A G Konoplyannikov, A I Parfenov
Format: Artigo
Langue:Russo
Publié: "Consilium Medicum" Publishing house 2018-03-01
Collection:Терапевтический архив
Sujets:
crohn's disease
infliximab
fistula form
mesenchymal stromal cells
stem cell therapy
Accès en ligne:https://ter-arkhiv.ru/0040-3660/article/viewFile/32743/pdf
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires